NeoGenomics Inc (NEO)
14.03
-0.13
(-0.92%)
USD |
NASDAQ |
Apr 24, 16:00
14.03
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Free Cash Flow (Quarterly): 10.73M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.73M |
| September 30, 2023 | -9.771M |
| June 30, 2023 | -9.042M |
| March 31, 2023 | -22.62M |
| December 31, 2022 | -8.219M |
| September 30, 2022 | -24.12M |
| June 30, 2022 | -27.29M |
| March 31, 2022 | -37.26M |
| December 31, 2021 | -31.76M |
| September 30, 2021 | -22.74M |
| June 30, 2021 | -22.74M |
| March 31, 2021 | -13.62M |
| December 31, 2020 | -5.52M |
| September 30, 2020 | -7.331M |
| June 30, 2020 | -3.144M |
| March 31, 2020 | -11.64M |
| December 31, 2019 | -2.717M |
| September 30, 2019 | 11.32M |
| June 30, 2019 | -8.162M |
| March 31, 2019 | 2.901M |
| December 31, 2018 | 12.23M |
| September 30, 2018 | 6.233M |
| June 30, 2018 | 2.363M |
| March 31, 2018 | 9.646M |
| December 31, 2017 | 2.236M |
| Date | Value |
|---|---|
| September 30, 2017 | 5.133M |
| June 30, 2017 | 1.671M |
| March 31, 2017 | -4.693M |
| December 31, 2016 | -2.449M |
| September 30, 2016 | 7.72M |
| June 30, 2016 | 2.612M |
| March 31, 2016 | 6.058M |
| December 31, 2015 | 1.588M |
| September 30, 2015 | 1.873M |
| June 30, 2015 | 2.346M |
| March 31, 2015 | -1.629M |
| December 31, 2014 | -0.067M |
| September 30, 2014 | 2.413M |
| June 30, 2014 | 3.19M |
| March 31, 2014 | 0.142M |
| December 31, 2013 | -1.03M |
| September 30, 2013 | 1.321M |
| June 30, 2013 | 1.494M |
| March 31, 2013 | -1.569M |
| December 31, 2012 | -0.351M |
| September 30, 2012 | -1.759M |
| June 30, 2012 | 0.345M |
| March 31, 2012 | -2.379M |
| December 31, 2011 | 0.68M |
| September 30, 2011 | -0.329M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.26M
Minimum
Mar 2022
11.32M
Maximum
Sep 2019
-12.93M
Average
-9.771M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Teladoc Health Inc | 93.58M |
| Abbott Laboratories | 2.283B |
| Halozyme Therapeutics Inc | 99.76M |
| Verastem Inc | -29.68M |
| Ocugen Inc | -14.02M |